1 |
Aggarwal BB, Shishodia S. Suppression of the nuclear factorkappaB activation pathway by spice-derived phytochemicalss: reasoning for seasoning. Ann N Y Acad Sci. 2004. 1030: 434-441.
DOI
ScienceOn
|
2 |
Checker R, Sandur SK, Sharma D, Patwardhan RS, Jayakumar S, Kohli V, Sethi G, Aggarwal BB, Sainis KB. Potent antiinflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of , AP-1 and NF-AT. PLoS One. 2012. 7: e31318.
DOI
|
3 |
Chen CC. Signal transduction pathways of inflammatory gene expressions and therapeutic implications. Curr Pharm Des. 2006. 12: 3497-3508.
DOI
ScienceOn
|
4 |
Chung MI, Jou SJ, Cheng HC, Lin CN, Ko FN, Teng CM. Antiplatelet constituents of formosan Rubia akane. J Nat Prod. 1994. 57: 313-316.
DOI
ScienceOn
|
5 |
Falvo JV, Tsytsykova AV, Goldfeld AE. Transcriptional control of the TNF gene. Curr Dir Autoimmun. 2010. 11: 27-60.
|
6 |
Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012. 33: 829-837.
DOI
ScienceOn
|
7 |
Gerstein NS, Schulman PM, Gerstein WH, Petersen TR, Tawil I. Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome. Ann Surg. 2012. 255: 811-819.
DOI
ScienceOn
|
8 |
Ho LK, Don MJ, Chen HC, Yeh SF, Chen JM. Inhibition of hepatitis B surface antigen secretion on human hepatoma cells. Components from Rubia cordifolia. J Nat Prod. 1996. 59: 330-333.
DOI
ScienceOn
|
9 |
Jun Y, Han CR, Choi MS, Bae MA, Woo MH, Kim YH. Effect of mollugin on apoptosis and adipogenesis of 3T3-L1 preadipocytes. Phytother Res. 2011. 25: 724-731.
DOI
|
10 |
Jung HW, Oh JS, Lee SH, Liang JL, Kim DH, Rahman AFM, Jahng Y. A facile synthesis of mollugin. Bull Korean Chem Soc. 2007. 28: 1863-1866.
DOI
|
11 |
Kawasaki Y, Goda Y, Yoshihira K. The mutagenic constituents of Rubia tinctorum. Chem Pharm Bull. 1992. 40: 1504-1509.
DOI
ScienceOn
|
12 |
Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci. 2004. 96: 229-245.
DOI
ScienceOn
|
13 |
Kleinert H, Schwarz PM, Förstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem. 2003. 384: 1343-1364.
|
14 |
Kuete V. Potential of Cameroonian plants and derived products against microbial infections: a review. Planta Med. 2010. 76: 1479-1491.
DOI
ScienceOn
|
15 |
Kundu JK, Surh YJ. 2008. Inflammation: gearing the journey to cancer. Mutat Res. 2008. 659: 15-30.
DOI
ScienceOn
|
16 |
Li JW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science. 2009. 325: 161-165.
DOI
ScienceOn
|
17 |
Li X, Stark GR. 2002. NFkappaB-dependent signaling pathways. Exp Hematol. 2002. 30: 285-296.
DOI
ScienceOn
|
18 |
Luqman S, Pezzuto JM. NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother Res. 2010. 24: 949-963.
|
19 |
Marec F, Kollarova I, Jegorov A. Mutagenicity of natural anthraquinones from Rubia tinctorum in the Drosophila wing spot test. Planta Med. 2001. 67: 127-131.
DOI
ScienceOn
|
20 |
Puangpraphant S, de Mejia EG. Saponins in yerba mate tea (Ilex paraguariensis A. St.-Hil) and quercetin synergistically inhibit iNOS and COX-2 in lipopolysaccharide-induced macrophages through pathways. J Agric Food Chem. 2009. 57: 8873-8883.
DOI
ScienceOn
|
21 |
Qi LW, Liu EH, Chu C, Peng YB, Cai HX, Li P. Anti-diabetic agents from natural products--an update from 2004 to 2009. Curr Top Med Chem. 2010. 10: 434-457.
DOI
ScienceOn
|
22 |
Stoffel A. The NF-kappaB signalling pathway: a therapeutic target in lymphoid malignancies? Expert Opin Ther Targets. 2005. 9: 1045-1061.
DOI
ScienceOn
|
23 |
Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, Hauschildt S. LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol. 2011. 31: 379-446.
DOI
|
24 |
Salminen A, Kauppinen A, Kaarniranta K. Phytochemicals suppress nuclear factor- signaling: impact on health span and the aging process. Curr Opin Clin Nutr Metab Care. 2012. 15: 23 -28.
DOI
ScienceOn
|
25 |
Smith WL, Urade Y, Jakobsson PJ. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem Rev. 2011. 111: 5821-5865.
DOI
ScienceOn
|
26 |
Vitiello M, Galdiero M, Finamore E, Galdiero S, Galdiero M. as a potential therapeutic target in microbial diseases. Mol Biosyst. 2012. 8: 1108-1120.
DOI
ScienceOn
|
27 |
Wang H, Cho CH. Effect of signaling on apoptosis in chronic inflammation-associated carcinogenesis. Curr Cancer Drug Targets. 2010. 10: 593-599.
DOI
ScienceOn
|
28 |
Whitehouse MW. Anti-inflammatory glucocorticoid drugs: reflections after 60 years. Inflammopharmacology. 2011. 19: 1-19.
DOI
ScienceOn
|
29 |
Wu KK. Control of COX-2 and iNOS gene expressions by aspirin and salicylate. Thromb Res. 2003. 110: 273-276.
DOI
|
30 |
Yuan JM, Sun C, Butler LM. Tea and cancer prevention: epidemiological studies. Pharmacol Res. 2011. 64: 123-135.
DOI
ScienceOn
|
31 |
Zauderer MG, Krug LM. Novel therapies in phase II and III trials for malignant pleural mesothelioma. J Natl Compr Canc Netw. 2012. 10: 42-47.
DOI
|